1-6 of 6
Scott Koenig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

Paul A. Moore, Wenjun Zhang, G. Jonah Rainey, Steve Burke, Hua Li, Ling Huang, Sergey Gorlatov, Maria Concetta Veri, Sudeepta Aggarwal, Yinhua Yang, Kalpana Shah, Linda Jin, Sunan Zhang, Leilei He, Tengfei Zhang, Valentina Ciccarone, Scott Koenig, Ezio Bonvini, Syd Johnson
Journal: Blood
Blood (2011) 117 (17): 4542–4551.
https://doi.org/10.1182/blood-2010-09-306449
Published: 2011
Includes: Supplemental data
Journal Articles

CD32B Expression Reflects Phenotypic and Functional Heterogeneity in Multiple Myeloma (MM)

Ping Zhou, MD, PhD, Adam M Boruchov, MD, James E. Hoffman, MD, Qianxing Mo, Adam Olshen, Evan Glasner, Ezio Bonvini, Scott Koenig, Ellen Drieghe, Martin Fleisher, PhD, Peter Maslak, MD, Hani Hassoun, MD, Adam D Cohen, MD, Heather Landau, MD, James W. Young, MD, Suresh C Jhanwar, PhD, Stephen D Nimer, MD, Raymond L Comenzo
Journal: Blood
Blood (2008) 112 (11): 842.
https://doi.org/10.1182/blood.V112.11.842.842
Published: 2008
Journal Articles

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody–based therapy

Brief Report
Ping Zhou, Raymond L. Comenzo, Adam B. Olshen, Ezio Bonvini, Scott Koenig, Peter G. Maslak, Martin Fleisher, James Hoffman, Suresh Jhanwar, James W. Young, Stephen D. Nimer, Adam M. Boruchov
Journal: Blood
Blood (2008) 111 (7): 3403–3406.
https://doi.org/10.1182/blood-2007-11-125526
Published: 2008
Journal Articles

An Fc-Optimized Monoclonal Antibody Against CD32B, the Human Inhibitory Fc- γ Receptor IIB, in the Immunotherapy of B-Cell Malignanacy.

Jeffrey B. Stavenhagen, PhD, Sergey Gorlatov, Ph.D., Nadine Tuaillon, Ph.D., Christopher T. Rankin, Ph.D., Maria-Concetta Veri, Ph.D., David Inzunza, M.D., Stephen Burke, Ling Huang, Hua Li, Shannon Thomas, Syd Johnson, Ph.D., Jeffrey Ravetch, M.D., Ph.D., Scott Koenig, M.D., Ph.D., Ezio Bonvini, MD
Journal: Blood
Blood (2006) 108 (11): 2529.
https://doi.org/10.1182/blood.V108.11.2529.2529
Published: 2006
Journal Articles

CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma

Christopher T. Rankin, Maria-Concetta Veri, Sergey Gorlatov, Nadine Tuaillon, Steve Burke, Ling Huang, H. David Inzunza, Hua Li, Shannon Thomas, Syd Johnson, Jeffrey Stavenhagen, Scott Koenig, Ezio Bonvini
Journal: Blood
Blood (2006) 108 (7): 2384–2391.
https://doi.org/10.1182/blood-2006-05-020602
Published: 2006
Includes: Supplemental data
Journal Articles

Rituximab Variants with Re-Engineered Fc with Higher Affinity to Activating Fcγ R Eliminate the Functional Difference between Fcγ R Genotypes.

Wen-Kai Weng, MD, PhD, Jeffrey Stavenhagen, PhD, Scott Koenig, MD, PhD, Ronald Levy, MD
Journal: Blood
Blood (2005) 106 (11): 347.
https://doi.org/10.1182/blood.V106.11.347.347
Published: 2005